Skip to main content
Erschienen in: World Journal of Surgery 10/2016

11.05.2016 | Original Scientific Report

Validation of a Nomogram to Predict the Risk of Perioperative Blood Transfusion for Liver Resection

verfasst von: Fabio Bagante, Gaya Spolverato, Andrea Ruzzenente, Ana Wilson, Faiz Gani, Simone Conci, Alexander Yahanda, Tommaso Campagnaro, Alfredo Guglielmi, Timothy M. Pawlik

Erschienen in: World Journal of Surgery | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Nomograms may be important clinical tools to estimate the preoperative risk of transfusion and allow for preemptive arrangements for alternatives to allogeneic blood transfusions.

Methods

A multicentric international cohort of 1345 patients who underwent hepatectomy for benign or malign liver diseases was used to validate a nomogram developed by the Memorial Sloan-Kettering Cancer Center.

Results

A total of 449 (33.3 %) patients received a blood transfusion after hepatectomy. Several variables were associated with the need of transfusion on univariate analysis: age, BMI, hemoglobin, PT-INR, bilirubin, AST, ALT, GGT, albumin, primary liver cancer, and number of segments resected. The MSKCC nomogram, including the number of segments resected, diagnosis (primary vs. non-primary), extrahepatic organ resection, as well as platelet and hemoglobin levels, had a good predictive ability (AUC = 0.69). The frequency of patients transfused ranged from 19 % for patients who were at “low risk” (<20 % risk to be transfused) up to 68 % for patients at “high risk” (>70 % risk to be transfused). The nomogram was tested in a multivariable model including other factors associated with risk of transfusion. The final model included age (OR 1.02, 95 % CI 1.01–1.03, p < 0.001), PT-INR (OR 1.54, 95 % CI 1.01–2.36, p = 0.048), and bilirubin (OR 1.86, 95 % CI 1.09–3.18, p = 0.021). The prediction ability for the integrated prediction model was AUC = 0.73.

Conclusion

The MSKCC nomogram was an effective clinical tool able to predict the perioperative risk of transfusion in our independent external validation. The inclusion of patient age, as well as factors associated with liver functional status (bilirubin and PT-INR), improved the predictive ability of the MSKCC nomogram.
Literatur
1.
Zurück zum Zitat Nelson-Williams H, Gani F, Kilic A et al (2015) Factors associated with interhospital variability in inpatient costs of liver and pancreatic resections. JAMA Surg 42:1–9 Nelson-Williams H, Gani F, Kilic A et al (2015) Factors associated with interhospital variability in inpatient costs of liver and pancreatic resections. JAMA Surg 42:1–9
2.
Zurück zum Zitat Virani S, Michaelson JS, Hutter MM et al (2007) Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg 204:1284–1292CrossRefPubMed Virani S, Michaelson JS, Hutter MM et al (2007) Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg 204:1284–1292CrossRefPubMed
3.
4.
Zurück zum Zitat Egger ME, Ohlendorf JM, Scoggins CR et al (2015) Assessment of the reporting of quality and outcome measures in hepatic resections: a call for 90-day reporting in all hepatectomy series. HPB 17:839–845CrossRefPubMedPubMedCentral Egger ME, Ohlendorf JM, Scoggins CR et al (2015) Assessment of the reporting of quality and outcome measures in hepatic resections: a call for 90-day reporting in all hepatectomy series. HPB 17:839–845CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Ejaz A, Frank SM, Spolverato G et al (2015) Variation in the use of type and crossmatch blood ordering among patients undergoing hepatic and pancreatic resections. Surgery 55(11):2770 Ejaz A, Frank SM, Spolverato G et al (2015) Variation in the use of type and crossmatch blood ordering among patients undergoing hepatic and pancreatic resections. Surgery 55(11):2770
7.
Zurück zum Zitat Kooby DA, Stockman J, Ben-Porat L et al (2003) Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 237:860–869 discussion 869–870 PubMedPubMedCentral Kooby DA, Stockman J, Ben-Porat L et al (2003) Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 237:860–869 discussion 869–870 PubMedPubMedCentral
8.
Zurück zum Zitat Gozzetti G, Mazziotti A, Grazi GL et al (1995) Liver resection without blood transfusion. Br J Surg 82:1105–1110CrossRefPubMed Gozzetti G, Mazziotti A, Grazi GL et al (1995) Liver resection without blood transfusion. Br J Surg 82:1105–1110CrossRefPubMed
9.
Zurück zum Zitat Rosen CB, Nagorney DM, Taswell HF et al (1992) Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 216:493–504 discussion 504–495 CrossRefPubMedPubMedCentral Rosen CB, Nagorney DM, Taswell HF et al (1992) Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 216:493–504 discussion 504–495 CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Asahara T, Katayama K, Itamoto T et al (1999) Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg 23:676–680. doi:10.1007/PL00012367 CrossRefPubMed Asahara T, Katayama K, Itamoto T et al (1999) Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg 23:676–680. doi:10.​1007/​PL00012367 CrossRefPubMed
11.
Zurück zum Zitat Dionigi G, Boni L, Rovera F et al (2009) Effect of perioperative blood transfusion on clinical outcomes in hepatic surgery for cancer. World J Gastroenterol 15:3976–3983CrossRefPubMedPubMedCentral Dionigi G, Boni L, Rovera F et al (2009) Effect of perioperative blood transfusion on clinical outcomes in hepatic surgery for cancer. World J Gastroenterol 15:3976–3983CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Park JO, Gonen M, D’Angelica MI et al (2007) Autologous versus allogeneic transfusions: no difference in perioperative outcome after partial hepatectomy autologous transfusion on hepatectomy outcome. J Gastrointest Surg 11:1286–1293CrossRefPubMed Park JO, Gonen M, D’Angelica MI et al (2007) Autologous versus allogeneic transfusions: no difference in perioperative outcome after partial hepatectomy autologous transfusion on hepatectomy outcome. J Gastrointest Surg 11:1286–1293CrossRefPubMed
13.
Zurück zum Zitat de Boer MT, Molenaar IQ (2007) Porte RJ Impact of blood loss on outcome after liver resection. Dig Surg 24:259–264CrossRefPubMed de Boer MT, Molenaar IQ (2007) Porte RJ Impact of blood loss on outcome after liver resection. Dig Surg 24:259–264CrossRefPubMed
14.
Zurück zum Zitat Gurusamy KS, Li J, Vaughan J et al (2012) Cardiopulmonary interventions to decrease blood loss and blood transfusion requirements for liver resection. Cochrane Database Syst Rev 5(CD00733):8 Gurusamy KS, Li J, Vaughan J et al (2012) Cardiopulmonary interventions to decrease blood loss and blood transfusion requirements for liver resection. Cochrane Database Syst Rev 5(CD00733):8
15.
Zurück zum Zitat Kim Y, Spolverato G, Lucas DJ et al (2015) Red cell transfusion triggers and postoperative outcomes after major surgery. J Gastrointest Surg 19:2062–2073CrossRefPubMed Kim Y, Spolverato G, Lucas DJ et al (2015) Red cell transfusion triggers and postoperative outcomes after major surgery. J Gastrointest Surg 19:2062–2073CrossRefPubMed
16.
Zurück zum Zitat Spolverato G, Kim Y, Ejaz A et al (2015) Effect of relative decrease in blood hemoglobin concentrations on postoperative morbidity in patients who undergo major gastrointestinal surgery. JAMA Surg 150:949–956CrossRefPubMed Spolverato G, Kim Y, Ejaz A et al (2015) Effect of relative decrease in blood hemoglobin concentrations on postoperative morbidity in patients who undergo major gastrointestinal surgery. JAMA Surg 150:949–956CrossRefPubMed
17.
Zurück zum Zitat Ejaz A, Spolverato G, Kim Y et al (2015) Impact of blood transfusions and transfusion practices on long-term outcome following hepatopancreaticobiliary surgery. J Gastrointest Surg 19:887–896CrossRefPubMed Ejaz A, Spolverato G, Kim Y et al (2015) Impact of blood transfusions and transfusion practices on long-term outcome following hepatopancreaticobiliary surgery. J Gastrointest Surg 19:887–896CrossRefPubMed
18.
Zurück zum Zitat Lucas DJ, Schexneider KI, Weiss M et al (2014) Trends and risk factors for transfusion in hepatopancreatobiliary surgery. J Gastrointest Surg 18:719–728CrossRefPubMed Lucas DJ, Schexneider KI, Weiss M et al (2014) Trends and risk factors for transfusion in hepatopancreatobiliary surgery. J Gastrointest Surg 18:719–728CrossRefPubMed
19.
Zurück zum Zitat Mavros MN, Xu L, Maqsood H et al (2015) Perioperative blood transfusion and the prognosis of pancreatic cancer surgery: systematic review and meta-analysis. Ann Surg Oncol 22:4382–4391CrossRefPubMed Mavros MN, Xu L, Maqsood H et al (2015) Perioperative blood transfusion and the prognosis of pancreatic cancer surgery: systematic review and meta-analysis. Ann Surg Oncol 22:4382–4391CrossRefPubMed
20.
Zurück zum Zitat Agrawal S, Belghiti J (2011) Oncologic resection for malignant tumors of the liver. Ann Surg 253:656–665CrossRefPubMed Agrawal S, Belghiti J (2011) Oncologic resection for malignant tumors of the liver. Ann Surg 253:656–665CrossRefPubMed
21.
Zurück zum Zitat Azoulay D, Eshkenazy R, Andreani P et al (2005) In situ hypothermic perfusion of the liver versus standard total vascular exclusion for complex liver resection. Ann Surg 241:277–285CrossRefPubMedPubMedCentral Azoulay D, Eshkenazy R, Andreani P et al (2005) In situ hypothermic perfusion of the liver versus standard total vascular exclusion for complex liver resection. Ann Surg 241:277–285CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Sima CS, Jarnagin WR, Fong Y et al (2009) Predicting the risk of perioperative transfusion for patients undergoing elective hepatectomy. Ann Surg 250:914–921CrossRefPubMed Sima CS, Jarnagin WR, Fong Y et al (2009) Predicting the risk of perioperative transfusion for patients undergoing elective hepatectomy. Ann Surg 250:914–921CrossRefPubMed
23.
Zurück zum Zitat Pang YY (2002) The Brisbane 2000 terminology of liver anatomy and resections. HPB 2000; 2:333–39. HPB 4:99 author reply 99–100 CrossRefPubMed Pang YY (2002) The Brisbane 2000 terminology of liver anatomy and resections. HPB 2000; 2:333–39. HPB 4:99 author reply 99–100 CrossRefPubMed
24.
Zurück zum Zitat Carson JL, Grossman BJ, Kleinman S et al (2012) Red blood cell transfusion: a clinical practice guideline from the AABB*. Ann Intern Med 157:49–58CrossRefPubMed Carson JL, Grossman BJ, Kleinman S et al (2012) Red blood cell transfusion: a clinical practice guideline from the AABB*. Ann Intern Med 157:49–58CrossRefPubMed
25.
Zurück zum Zitat Keller EJ, Kwo PY, Helft PR (2014) Ethical considerations surrounding survival benefit-based liver allocation. Liver Transpl 20:140–146CrossRefPubMed Keller EJ, Kwo PY, Helft PR (2014) Ethical considerations surrounding survival benefit-based liver allocation. Liver Transpl 20:140–146CrossRefPubMed
27.
Zurück zum Zitat Allen PJ, Jarnagin WR (2003) Current status of hepatic resection. Adv Surg 37:29–49PubMed Allen PJ, Jarnagin WR (2003) Current status of hepatic resection. Adv Surg 37:29–49PubMed
28.
Zurück zum Zitat Poon RT (2004) Recent advances in techniques of liver resection. Surg Technol Int 13:71–77PubMed Poon RT (2004) Recent advances in techniques of liver resection. Surg Technol Int 13:71–77PubMed
29.
Zurück zum Zitat Nagino M, Kamiya J, Arai T et al (2005) One hundred consecutive hepatobiliary resections for biliary hilar malignancy: preoperative blood donation, blood loss, transfusion, and outcome. Surgery 137:148–155CrossRefPubMed Nagino M, Kamiya J, Arai T et al (2005) One hundred consecutive hepatobiliary resections for biliary hilar malignancy: preoperative blood donation, blood loss, transfusion, and outcome. Surgery 137:148–155CrossRefPubMed
30.
Zurück zum Zitat Kamiyama T, Nakanishi K, Yokoo H et al (2010) Perioperative management of hepatic resection toward zero mortality and morbidity: analysis of 793 consecutive cases in a single institution. J Am Coll Surg 211:443–449CrossRefPubMed Kamiyama T, Nakanishi K, Yokoo H et al (2010) Perioperative management of hepatic resection toward zero mortality and morbidity: analysis of 793 consecutive cases in a single institution. J Am Coll Surg 211:443–449CrossRefPubMed
31.
Zurück zum Zitat Chien-Wei S, Gar-Yang C, Hung-Hsu H et al (2012) The roadmap concept for the management of hepatocellular carcinoma after surgical resection. Hepatology 56:112A Chien-Wei S, Gar-Yang C, Hung-Hsu H et al (2012) The roadmap concept for the management of hepatocellular carcinoma after surgical resection. Hepatology 56:112A
32.
Zurück zum Zitat Imamura H, Seyama Y, Kokudo N et al (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138:1198–1206 discussion 1206 CrossRefPubMed Imamura H, Seyama Y, Kokudo N et al (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138:1198–1206 discussion 1206 CrossRefPubMed
33.
Zurück zum Zitat Schiergens TS, Rentsch M, Kasparek MS et al (2015) Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases. Dis Colon Rectum 58:74–82CrossRefPubMed Schiergens TS, Rentsch M, Kasparek MS et al (2015) Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases. Dis Colon Rectum 58:74–82CrossRefPubMed
34.
Zurück zum Zitat Koch CG, Li L, Sessler DI et al (2008) Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 358:1229–1239CrossRefPubMed Koch CG, Li L, Sessler DI et al (2008) Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 358:1229–1239CrossRefPubMed
35.
Zurück zum Zitat Shander A (2004) Emerging risks and outcomes of blood transfusion in surgery. Semin Hematol 41:117–124CrossRefPubMed Shander A (2004) Emerging risks and outcomes of blood transfusion in surgery. Semin Hematol 41:117–124CrossRefPubMed
36.
Zurück zum Zitat Vamvakas EC, Blajchman MA (2007) Transfusion-related immunomodulation (TRIM): an update. Blood Rev 21:327–348CrossRefPubMed Vamvakas EC, Blajchman MA (2007) Transfusion-related immunomodulation (TRIM): an update. Blood Rev 21:327–348CrossRefPubMed
37.
Zurück zum Zitat Napolitano LM (2004) Current status of blood component therapy in surgical critical care. Curr opin crit care 10:311–317CrossRefPubMed Napolitano LM (2004) Current status of blood component therapy in surgical critical care. Curr opin crit care 10:311–317CrossRefPubMed
38.
Zurück zum Zitat Kaneko M, Sasaki S, Ishimaru K et al (2015) The impact of perioperative allogeneic blood transfusion on survival in elderly patients with colorectal cancer. Anticancer Res 35:3553–3558PubMed Kaneko M, Sasaki S, Ishimaru K et al (2015) The impact of perioperative allogeneic blood transfusion on survival in elderly patients with colorectal cancer. Anticancer Res 35:3553–3558PubMed
39.
Zurück zum Zitat Ghinea R, Greenberg R, White I et al (2013) Perioperative blood transfusion in cancer patients undergoing laparoscopic colorectal resection: risk factors and impact on survival. Tech Coloproctol 17:549–554CrossRefPubMed Ghinea R, Greenberg R, White I et al (2013) Perioperative blood transfusion in cancer patients undergoing laparoscopic colorectal resection: risk factors and impact on survival. Tech Coloproctol 17:549–554CrossRefPubMed
40.
Zurück zum Zitat Acheson AG, Brookes MJ, Spahn DR (2012) Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann Surg 256:235–244CrossRefPubMed Acheson AG, Brookes MJ, Spahn DR (2012) Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann Surg 256:235–244CrossRefPubMed
41.
Zurück zum Zitat Sun C, Wang Y, Yao HS et al (2015) Allogeneic blood transfusion and the prognosis of gastric cancer patients: systematic review and meta-analysis. Int J Surg 13:102–110CrossRefPubMed Sun C, Wang Y, Yao HS et al (2015) Allogeneic blood transfusion and the prognosis of gastric cancer patients: systematic review and meta-analysis. Int J Surg 13:102–110CrossRefPubMed
42.
Zurück zum Zitat Yao HS, Wang Q, Wang WJ et al (2008) Intraoperative allogeneic red blood cell transfusion in ampullary cancer outcome after curative pancreatoduodenectomy: a clinical study and meta-analysis. World J Surg 32:2038–2046. doi:10.1007/s00268-008-9675-9 CrossRefPubMed Yao HS, Wang Q, Wang WJ et al (2008) Intraoperative allogeneic red blood cell transfusion in ampullary cancer outcome after curative pancreatoduodenectomy: a clinical study and meta-analysis. World J Surg 32:2038–2046. doi:10.​1007/​s00268-008-9675-9 CrossRefPubMed
43.
Zurück zum Zitat Jarnagin WR, Gonen M, Fong Y et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg 236:397–406 discussion 406–397 CrossRefPubMedPubMedCentral Jarnagin WR, Gonen M, Fong Y et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg 236:397–406 discussion 406–397 CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Pulitano C, Arru M, Bellio L et al (2007) A risk score for predicting perioperative blood transfusion in liver surgery. Br J Surg 94:860–865CrossRefPubMed Pulitano C, Arru M, Bellio L et al (2007) A risk score for predicting perioperative blood transfusion in liver surgery. Br J Surg 94:860–865CrossRefPubMed
45.
Zurück zum Zitat Morris EJ, Forman D, Thomas JD et al (2010) Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg 97:1110–1118CrossRefPubMed Morris EJ, Forman D, Thomas JD et al (2010) Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg 97:1110–1118CrossRefPubMed
46.
Zurück zum Zitat Pawlik TM, Esnaola NF, Vauthey JN (2004) Surgical treatment of hepatocellular carcinoma: similar long-term results despite geographic variations. Liver Transpl 10:S74–S80CrossRefPubMed Pawlik TM, Esnaola NF, Vauthey JN (2004) Surgical treatment of hepatocellular carcinoma: similar long-term results despite geographic variations. Liver Transpl 10:S74–S80CrossRefPubMed
47.
Zurück zum Zitat Chen PJ, Furuse J, Han KH et al (2010) Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: experts’ opinion. Liver Int 30:1427–1438CrossRefPubMed Chen PJ, Furuse J, Han KH et al (2010) Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: experts’ opinion. Liver Int 30:1427–1438CrossRefPubMed
48.
Zurück zum Zitat Chan FK, Cheng KC (2014) Laparoscopic liver resection: western versus eastern experience. Chin J Cancer Res 26:243–244PubMedPubMedCentral Chan FK, Cheng KC (2014) Laparoscopic liver resection: western versus eastern experience. Chin J Cancer Res 26:243–244PubMedPubMedCentral
Metadaten
Titel
Validation of a Nomogram to Predict the Risk of Perioperative Blood Transfusion for Liver Resection
verfasst von
Fabio Bagante
Gaya Spolverato
Andrea Ruzzenente
Ana Wilson
Faiz Gani
Simone Conci
Alexander Yahanda
Tommaso Campagnaro
Alfredo Guglielmi
Timothy M. Pawlik
Publikationsdatum
11.05.2016
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 10/2016
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-016-3544-8

Weitere Artikel der Ausgabe 10/2016

World Journal of Surgery 10/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.